BGI Europe

BGI Europe's main business is to provide research services and comprehensive precision medicine testing solutions for scientific research institutions, enterprises and public institutions, medical institutions, and social health organizations through multi-omics big data technologies such as genetic testing, mass spectrometry testing, and bioinformatics analysis.Adhering to the vision of "Genomic Science for the Benefit of Humanity," BGI aims to promote the advancement of life science research, the application of life big data, and improve global healthcare standards. Based on genomic research achievements and precision testing technology applications in public health, the company is committed to accelerating technological innovation, reducing birth defects, strengthening cancer prevention and control, mitigating the harm of major diseases to humanity, achieving precise treatment of infections, and fully supporting precision medicine.The company relies on world-leading bioinformatics R&D, transformation, and application platforms, with hundreds of high-throughput sequencers, mass spectrometers, and high-performance computers, providing strong support for data generation, storage, and analysis.